61788 Tildrakizumab improves high burdensome symptoms and overall well-being in patients with moderate-to-severe plaque psoriasis

Loading...
Thumbnail Image

LTHT Author

LTHT Department

Contributor Profession (Non Medical)

Publication Date

Item Type

Article

Language

Subject

Subject Headings

Journal Title

Journal ISSN

Volume Title

Abstract

Journal

Journal of the American Academy of Dermatology

Link to Publisher Site (DOI)

Endorsement

Review

Supplemented By

Referenced By